Spire Healthcare Group (LON:SPI) Sets New 52-Week High - Time to Buy?

Key Points

• Spire Healthcare Group's stock reached a new 52-week high of GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33), with a trading volume of approximately 9.7 million shares.
• Analysts have given Spire Healthcare an average rating of "Buy," with a price target ranging from GBX 280 to GBX 303, indicating positive sentiment from investment firms.
• The company reported quarterly earnings of GBX 4.10 per share, with an anticipated annual earnings per share forecast of approximately 15.66 for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price hit a new 52-week high during trading on Saturday . The stock traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34), with a volume of 9747062 shares trading hands. The stock had previously closed at GBX 216.50 ($2.93).

Wall Street Analyst Weigh In

SPI has been the topic of several recent analyst reports. JPMorgan Chase & Co. decreased their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research note on Tuesday, August 5th. Berenberg Bank restated a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of GBX 294.33.

Spire Healthcare Group Stock Up 4.7%

The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The company has a market cap of £991.84 million, a price-to-earnings ratio of 5,358.70, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The business has a 50-day simple moving average of GBX 218.99 and a 200-day simple moving average of GBX 203.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, equities analysts anticipate that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.